We are live on
!
Find out more
HCM
Harvey Capital Management Portfolio holdings
AUM
$439M
1-Year Est. Return
37.68%
This Fund
S&P 500
This Quarter
Est. Return
+11.12%
1 Year Est. Return
+37.68%
3 Year Est. Return
+140.63%
5 Year Est. Return
+188.51%
10 Year Est. Return
+681.53%
AUM
$303M
AUM Growth
+$27.4M
(+9.9%)
Cap. Flow
+$1.01M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
43.11%
Holding
87
New
9
Increased
24
Reduced
27
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$3.09M |
| 2 |
Star Bulk Carriers
SBLK
|
+$2.83M |
| 3 |
Nutrien
NTR
|
+$2.4M |
| 4 |
United Rentals
URI
|
+$2.38M |
| 5 |
Fidelity National Information Services
FIS
|
+$2.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.67M |
| 2 |
Oracle
ORCL
|
+$3.1M |
| 3 |
Microsoft
MSFT
|
+$1.77M |
| 4 |
IBDM
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
|
+$1.53M |
| 5 |
IBDN
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
|
+$1.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.98% |
| 2 | Financials | 15.19% |
| 3 | Consumer Discretionary | 14.4% |
| 4 | Communication Services | 14.29% |
| 5 | Healthcare | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGC
76
Canopy Growth
CGC
$391M
| $241K | 0.08% |
1,000
+250
| +33% | +$64K |
|
|
ALXN
77
DELISTED
Alexion Pharmaceuticals
ALXN
| $220K | 0.07% |
+1,200
| New | +$206K |
|
|
78
Becton Dickinson
BDX
$47B
| – | – |
-15,481
| Closed | -$3.67M |
|
79
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
| – | – |
-38,000
| Closed | -$965K |
|
80
CRISPR Therapeutics
CRSP
$5.13B
| – | – |
-2,500
| Closed | -$304K |
|
81
iShares National Muni Bond ETF
MUB
$45.4B
| – | – |
-6,500
| Closed | -$754K |
|
82
Okta
OKTA
$25.8B
| – | – |
-2,000
| Closed | -$440K |
|
83
Paysafe
PSFE
$416M
| – | – |
-1,667
| Closed | -$270K |
|
84
WIX.com
WIX
$2.79B
| – | – |
-3,000
| Closed | -$837K |
|
|
IBDO
85
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| – | – |
-13,716
| Closed | -$358K |
|
|
IBDN
86
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
| – | – |
-43,450
| Closed | -$1.11M |
|
|
IBDM
87
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
| – | – |
-61,520
| Closed | -$1.53M |
|
Similar funds
CDMG
WAS
DCM
SCP
CAAM
SPT
BCM
VBA
Harvey Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Harvey Capital Management held 87 positions worth $303M, up 9.9% from $276M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Harvey Capital Management's Q2 2021 filing shows 9 new, 24 increased, 27 reduced and 10 closed positions. Its largest new stake was Star Bulk Carriers: 143,125 shares worth $3.28M. The largest sale was Becton Dickinson, an estimated $3.67M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Harvey Capital Management's largest Q2 2021 buy was Star Bulk Carriers: 143,125 shares worth $3.28M.
- Harvey Capital Management added most to Regeneron Pharmaceuticals in Q2 2021, an estimated $3.09M increase.
- Harvey Capital Management's biggest Q2 2021 reduction was Oracle, cutting an estimated $3.1M.
- Harvey Capital Management fully exited Becton Dickinson in Q2 2021, selling an estimated $3.67M.
- Harvey Capital Management's ten largest holdings make up 43% of its $303M portfolio in Q2 2021.
- Harvey Capital Management opened 9 new positions and closed 10 in Q2 2021.
- Harvey Capital Management's portfolio value rose 9.9% quarter-over-quarter to $303M.
Based on Harvey Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.